| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |